The anti-inflammatory effects of SGLT inhibitors

Aging (Albany NY). 2019 Aug 25;11(16):5866-5867. doi: 10.18632/aging.102175. Epub 2019 Aug 25.

Authors

Álvaro García-Ropero^{1

2}, Carlos G Santos-Gallego¹, Juan J Badimon¹

Affiliations

¹ Atherothrombosis Research Unit. Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
² Cardiology Department, Imperial College London, The Royal Brompton and Harefield Hospital, London, United Kingdom.

No abstract available

Keywords: SGLT inhibitors; anti-inflammatory effects; cardiovascular mortality; diabetes mellitus; empagliflozin; inflammation.

Publication types

Editorial

MeSH terms

Animals
Anti-Inflammatory Agents / therapeutic use*
Diabetes Mellitus, Type 2 / drug therapy
Hypoglycemic Agents / therapeutic use
Inflammation / drug therapy*
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*

Substances

Anti-Inflammatory Agents
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors